BITS Pilani Institutional Repository: Browsing DSpace

Browsing by Author Mahesh, R.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:

Showing results 90 to 109 of 112 < previous next >

Issue Date	Title	Author(s)
2015	Pharmacological evaluation of novel 5-HT3 receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery	Mahesh, R.
2004	Pharmacophore Based Synthesis of 3-Chloroquinoxaline-2-carboxamides as Serotonin3 (5-HT3) Receptor Antagonist	Mahesh, R.
2016-06	Pioglitazone, a PPARγ agonist rescues depression associated with obesity using chronic unpredictable mild stress model in experimental mice	Mahesh, R.
2015-01	Piperazine Analogs of Naphthyridine-3-carboxamides and Indole-2-carboxamides: Novel 5-HT3 Receptor Antagonists with Antidepressant-Like Activity	Mahesh, R.
2015-01	Piperazine Analogs of Naphthyridine‐3‐carboxamides and Indole‐2‐carboxamides: Novel 5‐HT3 Receptor Antagonists with Antidepressant‐Like Activity	Mahesh, R.
2007-12	Potential antidepressants: Pharmacology of 2-(4-methyl piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile in rodent behavioural models	Mahesh, R.
2014-07	Protective effects of a novel 5-HT3 receptor antagonist, N-n-butyl-3-methoxy quinoxaline-2-carboxamide (6o) against chronic unpredictable mild stress-induced behavioral changes and biochemical alterations	Mahesh, R.
2015-10	Pyridine-based, microwave-assisted one-pot synthetic protocol for the synthesis of ethyl 3-substituted-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates	Mahesh, R.
2013-11	QCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice	Mahesh, R.
2015-01	QCM-4, a 5-HT3 receptor antagonist ameliorates plasma HPA axis hyperactivity, leptin resistance and brain oxidative stress in depression and anxiety-like behavior in obese mice	Mahesh, R.
2014-10	QCM-4, a serotonergic type 3 receptor modulator attenuates depression co-morbid with obesity in mice: An approach based on behavioral and biochemical investigations	Mahesh, R.
2011-01	Quinoxalin-2-carboxamides: synthesis and pharmacological evaluation as serotonin type-3 (5-HT3) receptor antagonists	Mahesh, R.
2016-01	Rational design, synthesis and in vitro evaluation of allylidene hydrazinecarboximidamide derivatives as BACE-1 inhibitors	Mahesh, R.
2010-02	Review: The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?	Mahesh, R.
2013-07	Role of Hypothalamic-pituitary-adrenal-axis in Affective Disorders: Anti-depressant and Anxiolytic Activity of Partial 5-HT1A Agonist in Adrenalectomised Rats	Mahesh, R.
2014-04	Role of Serotonin Type-1A/B (Hydroxytryptamine) Receptors in Depression Revisited	Mahesh, R.
2006-05	Synthesis and biological evaluation of a novel structural type of serotonin 5-HT3 receptor antagonists	Mahesh, R.
1997-05-02	Synthesis and pharmacological evaluation of N-Phenylbenzylamine Imidazo(2,1-b) Benzothiazole derivatives as H1 Receptor Antagonistis and Quinoxaline Carboxamides as 5-HT receptor Antagonistis	Mahesh, R.
2009	TAFI: A Potential Target for Fibrinolytic Drugs	Mahesh, R.
2010	Traumatic brain injury: severity, pathophysiology and neurobehavioural outcome	Mahesh, R.

Showing results 90 to 109 of 112 < previous next >